|
Anderson, Jeffrey A; Archin, Nancie M; Ince, William et al. (2011) Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells. J Virol 85:5220-3
|
|
Archin, Nancie M; Cheema, Manzoor; Parker, Daniel et al. (2010) Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. PLoS One 5:e9390
|
|
Keedy, Kara S; Margolis, David M (2010) Therapy for persistent HIV. Trends Pharmacol Sci 31:206-11
|
|
Bowman, Mary-Catherine; Archin, Nancie M; Margolis, David M (2009) Pharmaceutical approaches to eradication of persistent HIV infection. Expert Rev Mol Med 11:e6
|
|
Keedy, Kara S; Archin, Nancie M; Gates, Adam T et al. (2009) A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 83:4749-56
|
|
Bowman, Mary-Catherine; Ballard, T Eric; Ackerson, Christopher J et al. (2008) Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130:6896-7
|
|
Klichko, Vladimir; Archin, Nancy; Kaur, Rupinderjeet et al. (2006) Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation. J Virol 80:4570-9
|
|
Lehrman, Ginger; Hogue, Ian B; Palmer, Sarah et al. (2005) Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549-55
|
|
Ylisastigui, Loyda; Kaur, Rupinderjeet; Johnson, Holly et al. (2005) Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter. J Virol 79:5952-62
|
|
Ylisastigui, Loyda; Archin, Nancie M; Lehrman, Ginger et al. (2004) Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18:1101-8
|
Showing the most recent 10 out of 14 publications
